Adial Pharmaceuticals Inc
General ticker "ADIL" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $6.4M
Adial Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -25.3%.
Estimated limits based on current volatility of 2.3%: low 1.01$, high 1.05$
Short-term ADIL quotes
Long-term ADIL plot
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
Operating Expenses | $19.29MM | $13.32MM | $6.89MM |
Operating Income | $-19.29MM | $-13.32MM | $-6.89MM |
Non-Operating Income | $-0.23MM | $0.59MM | $-0.11MM |
R&D Expense | $8.40MM | $4.18MM | $1.27MM |
Income(Loss) | $-19.52MM | $-12.73MM | $-7.00MM |
Taxes | $-0.09MM | $-0.00MM | $0.00MM |
Profit(Loss) | $-19.42MM | $-12.73MM | $-7.00MM |
Stockholders Equity | $3.51MM | $3.28MM | $4.08MM |
Assets | $7.47MM | $5.73MM | $4.74MM |
Operating Cash Flow | $-11.95MM | $-11.19MM | $-6.81MM |
Capital expenditure | $0.06MM | $0.00MM | $6.81MM |
Investing Cash Flow | $-0.03MM | $0.00MM | $1.50MM |
Financing Cash Flow | $13.64MM | $9.13MM | $4.13MM |
Earnings Per Share* | $-26.12 | $-11.98 | $-5.44 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.